What amount sold does Unreasonable EpiBone IV LLC report in Form D filings?

The latest linked filings report $90K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Unreasonable EpiBone IV LLC's most recent SEC filing?

Unreasonable EpiBone IV LLC's most recent Form D filing was on 2026-02-06.

How many investors does Unreasonable EpiBone IV LLC have?

The most recent Form D filing lists 1 investor(s).

Unreasonable EpiBone IV LLC

CIK: 0002092117·Pooled Investment Fund·Boulder, CO

Reported Sold

$89,736

Total Filings

Identified Offerings

Last Filed

Feb 6, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Feb 6, 2026Form D — New notice

Reported sold: $89,736 · Target: $89,736

Rule 506(b)·1 investor·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

N/A

Amendment Rate

Latest reported sold across 1 identified offering

$89,736

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Unreasonable Investment Management LLC

Promoter

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 6, 2026	New	$89,736	$89,736	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Spruceview U.S. Co-Investment Fund II, LP

Pooled Investment Fund

Offering target: $150,000,000

Filed Oct 30, 2026